Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis

被引:44
|
作者
Drinda, S [1 ]
Franke, S
Rüster, M
Petrow, P
Pullig, O
Stein, G
Hein, G
机构
[1] Univ Jena, Dept Internal Med 4, D-6900 Jena, Germany
[2] Univ Jena, Inst Pathol, D-6900 Jena, Germany
[3] Univ Erlangen Nurnberg, Div Orthoped Rheumatol, Erlangen, Germany
[4] Univ Jena, Klin Innere Med 4, D-07740 Jena, Germany
关键词
immunohistochemistry; receptor for advanced glycation end products (RAGE); rheumatoid arthritis; synovial tissue;
D O I
10.1007/s00296-004-0456-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Generation of advanced glycation end products ( AGE) is an inevitable process in vivo and can be accelerated under pathologic conditions such as oxidative stress, e. g. in rheumatoid arthritis ( RA). This process is mediated by the AGE-specific receptor ( RAGE). In this study we analysed the presence of RAGE in RA and osteoarthritic (OA) synovial tissue using immunohistology. Methods: Frozen synovial tissue samples from 11 RA patients and 12 OA patients were treated with goat anti-RAGE immunoglobulin G (IgG) and rabbit antigoat IgG. Immunostaining was visualised with streptavidin horse radish peroxidase ( chromogen amino-ethyl-carbazole). Cell differentiation was performed with antibodies against CD68, CD45RO, and CD20. Results: In 9/11 RA and 8/12 OA synovial specimens, RAGE was detected in synovial lining, sublining, and stroma. In RA, many T cells ( CD45RO(+)) and some macrophages ( CD68(+)) showed positive immunostaining for RAGE, whereas B cells were mostly negative. We found no difference in staining patterns between the RA and OA samples. Conclusions: We detected RAGE in RA and OA synovial tissue. The presence of RAGE on macrophages, T cells, and some B cells suggests its role in the pathogenesis of inflammatory joint disease.
引用
收藏
页码:411 / 413
页数:3
相关论文
共 50 条
  • [31] Identification of pheophorbide a as an inhibitor of receptor for advanced glycation end products in Mallotus japonicus
    Teruki Matsumoto
    Michiyo Matsuno
    Norihito Ikui
    Yoshiyuki Mizushina
    Yume Omiya
    Rikako Ishibashi
    Taro Ueda
    Hajime Mizukami
    Journal of Natural Medicines, 2021, 75 : 675 - 681
  • [32] Identification of pheophorbide a as an inhibitor of receptor for advanced glycation end products in Mallotus japonicus
    Matsumoto, Teruki
    Matsuno, Michiyo
    Ikui, Norihito
    Mizushina, Yoshiyuki
    Omiya, Yume
    Ishibashi, Rikako
    Ueda, Taro
    Mizukami, Hajime
    JOURNAL OF NATURAL MEDICINES, 2021, 75 (03) : 675 - 681
  • [33] Receptor for advanced glycation end products axis in critically ill patients
    C Ingels
    I Derese
    PJ Wouters
    G Van den Berghe
    I Vanhorebeek
    Critical Care, 18 (Suppl 1):
  • [34] The Expression of the Receptor for Advanced Glycation End-products in Fibroblast Like synoviocytes From Rheumatoid Arthritis Patients Is Induced by Interleukin-17.
    Jung, Young Ok
    Cho, Mila
    Kim, Hae-Rim
    Lee, Sang-Heon
    Park, Sung-Hwan
    Oh, Hye-Jwa
    Kim, Ho-Youn
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S26 - S26
  • [35] Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
    Lazzari, Tassia Kirchmann
    Cavalheiro, Erika
    Coutinho, Sandra Eugenia
    da Silva, Livia Fontes
    Silva, Denise Rossato
    PLOS ONE, 2021, 16 (07):
  • [36] Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?
    Christaki, Eirini
    Lazaridis, Nikolaos
    Opal, Steven M.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (03) : 304 - 311
  • [37] Receptor for Advanced Glycation End Products and Soluble Receptor for Advanced Glycation End Products: A Balancing Act in Chronic Obstructive Pulmonary Disease?
    Sukkar, Maria B.
    Postma, Dirkje S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (08) : 893 - 894
  • [38] Correction to: Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores
    Seyed Reza Najafizadeh
    Khatereh Amiri
    Maryam Moghaddassi
    Shaghayegh Khanmohammadi
    Hossein Mirmiranpour
    Manouchehr Nakhjavani
    Clinical Rheumatology, 2021, 40 : 4027 - 4027
  • [39] Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end productsRheumatoide Arthritis: Zusammenhänge zwischen kardiovaskulären Erkrankungen und dem "Advanced Glycation End Product Receptor"
    Lisa Carroll
    Suad Hannawi
    Thomas Marwick
    Ranjeny Thomas
    Wiener Medizinische Wochenschrift, 2006, 156 (1-2) : 42 - 52
  • [40] Understanding RAGE, the receptor for advanced glycation end products
    Bierhaus, A
    Humpert, PM
    Morcos, M
    Wendt, T
    Chavakis, T
    Arnold, B
    Stern, DM
    Nawroth, PP
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11): : 876 - 886